Our findings are consistent with studies demonstrating that in the presence of elevated tau burden in the brain and CSF, women display faster cognitive decline trajectories [15], and higher rates of clinical AD [14], compared to men. The gene discussed is MAPT; the disease is Alzheimer disease.